Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Leigh Perreault

Concepts (337)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prediabetic State
24
2024
252
6.730
Why?
Diabetes Mellitus, Type 2
50
2024
2521
4.920
Why?
Insulin Resistance
33
2025
1198
4.160
Why?
Hypoglycemic Agents
23
2023
1285
3.120
Why?
Obesity
29
2024
2974
2.710
Why?
Blood Glucose
31
2023
2183
2.530
Why?
Weight Loss
15
2024
770
2.170
Why?
Muscle, Skeletal
21
2024
1701
2.160
Why?
Cardiovascular Diseases
15
2020
2113
1.980
Why?
Insulin
20
2024
2398
1.810
Why?
Sphingolipids
7
2024
77
1.670
Why?
Diabetes Mellitus
11
2023
1035
1.610
Why?
Triglycerides
11
2024
525
1.560
Why?
Benzhydryl Compounds
3
2017
73
1.440
Why?
Glucose Intolerance
8
2020
146
1.430
Why?
Diabetic Angiopathies
3
2017
258
1.410
Why?
Diglycerides
6
2024
61
1.290
Why?
Diabetes Complications
2
2019
226
1.100
Why?
Overweight
7
2022
554
1.090
Why?
Glucosides
2
2017
44
1.070
Why?
Glucagon-Like Peptide 1
3
2023
133
0.980
Why?
Life Style
12
2020
485
0.980
Why?
Metformin
13
2023
328
0.900
Why?
Primary Health Care
6
2023
1756
0.880
Why?
Receptors, Gastrointestinal Hormone
1
2023
6
0.860
Why?
Exercise
11
2024
2024
0.860
Why?
Anti-Obesity Agents
2
2024
56
0.840
Why?
Glucose Tolerance Test
15
2021
361
0.840
Why?
Cannabidiol
1
2025
119
0.810
Why?
Glucose Clamp Technique
11
2024
194
0.800
Why?
Goals
2
2021
168
0.790
Why?
Adult
55
2025
37821
0.790
Why?
Dronabinol
1
2025
230
0.770
Why?
Humans
95
2025
137514
0.760
Why?
Nutrition Therapy
1
2022
37
0.730
Why?
Marijuana Use
1
2025
203
0.730
Why?
Health Equity
1
2023
99
0.710
Why?
Middle Aged
45
2024
33355
0.710
Why?
Liver
4
2014
1940
0.700
Why?
Adipose Tissue
4
2023
624
0.670
Why?
Primary Care Nursing
1
2019
4
0.660
Why?
Hyperglycemia
4
2014
346
0.650
Why?
Male
60
2025
67718
0.640
Why?
Female
65
2025
73162
0.630
Why?
Obesity Management
1
2018
8
0.600
Why?
Insulin, Long-Acting
1
2019
63
0.590
Why?
Microvessels
1
2019
86
0.590
Why?
Peripheral Vascular Diseases
1
2019
103
0.590
Why?
Infant, Newborn, Diseases
1
2019
113
0.580
Why?
Awareness
1
2019
104
0.570
Why?
Body Mass Index
12
2024
2369
0.570
Why?
Cannabis
1
2025
490
0.570
Why?
Fasting
4
2020
275
0.550
Why?
Ceramides
5
2024
118
0.540
Why?
Policy
1
2018
150
0.530
Why?
Precision Medicine
1
2021
426
0.530
Why?
Weight Reduction Programs
2
2017
117
0.530
Why?
Risk Management
1
2017
91
0.520
Why?
Risk Factors
19
2023
10356
0.520
Why?
Incretins
2
2021
22
0.520
Why?
Rest
2
2017
122
0.510
Why?
Choristoma
1
2015
21
0.490
Why?
Sleep Deprivation
5
2021
174
0.480
Why?
Insulin-Secreting Cells
2
2010
372
0.460
Why?
Weight Gain
4
2019
518
0.430
Why?
Inflammation
1
2025
2837
0.430
Why?
Lipid Metabolism
4
2021
511
0.420
Why?
Sarcolemma
3
2024
41
0.410
Why?
Glucose
4
2023
1018
0.400
Why?
Randomized Controlled Trials as Topic
4
2022
1465
0.390
Why?
Phenols
1
2013
101
0.390
Why?
Lipids
4
2024
664
0.390
Why?
Clinical Trials as Topic
1
2017
1047
0.390
Why?
Physical Endurance
5
2020
275
0.360
Why?
Fenofibrate
1
2011
29
0.350
Why?
Glucagon-Like Peptides
2
2022
56
0.350
Why?
Athletes
7
2024
406
0.340
Why?
Hypolipidemic Agents
1
2011
92
0.340
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2010
46
0.330
Why?
Palmitates
1
2009
18
0.330
Why?
Phosphatidylcholines
2
2024
148
0.330
Why?
Cross-Sectional Studies
9
2024
5427
0.320
Why?
Pyrazines
1
2010
92
0.320
Why?
Hospitalization
1
2019
2197
0.320
Why?
Aged
17
2023
23798
0.310
Why?
Triazoles
1
2010
151
0.310
Why?
Energy Metabolism
4
2021
895
0.300
Why?
Young Adult
13
2025
13243
0.290
Why?
Sleep
4
2021
754
0.290
Why?
Biomarkers
8
2023
4172
0.290
Why?
Sodium-Glucose Transporter 2
2
2017
24
0.270
Why?
Risk Reduction Behavior
3
2023
220
0.270
Why?
Diabetic Nephropathies
2
2020
293
0.270
Why?
Sex Characteristics
3
2021
766
0.270
Why?
Markov Chains
2
2018
124
0.260
Why?
Absenteeism
2
2018
49
0.260
Why?
Double-Blind Method
5
2024
1987
0.260
Why?
Health Services
2
2018
103
0.250
Why?
Sex Factors
5
2018
2074
0.250
Why?
Adiponectin
3
2018
241
0.240
Why?
Pilot Projects
2
2021
1703
0.230
Why?
Remission Induction
3
2019
287
0.230
Why?
Muscle Fibers, Skeletal
3
2024
216
0.230
Why?
Follow-Up Studies
6
2021
5139
0.230
Why?
Renal Insufficiency, Chronic
2
2022
616
0.230
Why?
Circadian Rhythm
3
2019
463
0.230
Why?
Carnitine
2
2024
83
0.220
Why?
Dietary Fats
3
2020
301
0.220
Why?
Lipogenesis
2
2017
60
0.220
Why?
Lipoprotein Lipase
1
2004
59
0.210
Why?
Hyperinsulinism
1
2024
121
0.210
Why?
Physical Exertion
1
2004
212
0.200
Why?
Oxidation-Reduction
4
2024
1059
0.200
Why?
Healthy Lifestyle
1
2023
34
0.200
Why?
Computer Simulation
2
2018
986
0.200
Why?
Diet, Reducing
3
2017
88
0.190
Why?
Energy Intake
4
2021
478
0.190
Why?
Socioeconomic Factors
2
2018
1286
0.190
Why?
Consensus
3
2020
685
0.190
Why?
Biopsy
3
2018
1132
0.190
Why?
Combined Modality Therapy
4
2019
1241
0.190
Why?
Cluster Analysis
1
2023
502
0.180
Why?
Endpoint Determination
2
2019
77
0.180
Why?
Prevalence
2
2019
2719
0.180
Why?
Dose-Response Relationship, Drug
3
2024
2066
0.180
Why?
Nephrology
1
2022
61
0.180
Why?
Glucose Transporter Type 4
1
2021
40
0.180
Why?
Cytosol
2
2020
227
0.180
Why?
Ambulatory Care Facilities
1
2023
233
0.170
Why?
Body Weight
4
2024
973
0.170
Why?
Risk Adjustment
1
2020
78
0.170
Why?
Endocrinologists
1
2020
13
0.160
Why?
New Zealand
1
2019
55
0.160
Why?
Cytosine
1
2019
49
0.160
Why?
Pragmatic Clinical Trials as Topic
1
2019
66
0.160
Why?
Endoplasmic Reticulum
2
2020
265
0.160
Why?
Fatty Liver
1
2021
242
0.150
Why?
Liraglutide
1
2019
30
0.150
Why?
Fatty Acids, Nonesterified
2
2019
159
0.150
Why?
Exercise Test
3
2015
621
0.150
Why?
Models, Econometric
1
2018
34
0.150
Why?
Retinal Diseases
1
2019
91
0.150
Why?
Postprandial Period
1
2019
105
0.140
Why?
Quinolizines
1
1997
9
0.140
Why?
Adolescent
8
2023
21555
0.140
Why?
United States
9
2023
14696
0.140
Why?
Colorado
3
2023
4521
0.140
Why?
Drug Combinations
1
2019
344
0.140
Why?
Tissue Plasminogen Activator
2
2018
225
0.140
Why?
Referral and Consultation
1
2023
780
0.140
Why?
Antiemetics
1
1997
47
0.140
Why?
Nausea
1
1997
115
0.140
Why?
Health Resources
1
2018
122
0.130
Why?
Cholesterol, HDL
2
2015
205
0.130
Why?
Vomiting
1
1997
133
0.130
Why?
Cytokines
1
2025
2095
0.130
Why?
Hysterectomy
1
1997
128
0.130
Why?
Severity of Illness Index
2
2018
2838
0.130
Why?
Odds Ratio
1
2019
1063
0.130
Why?
Surgical Wound Infection
1
2019
306
0.130
Why?
Patient-Centered Care
1
2021
527
0.130
Why?
Patient Participation
1
2019
423
0.120
Why?
Phosphatidylethanolamines
1
2016
77
0.120
Why?
Blotting, Western
2
2016
1227
0.120
Why?
Eating
2
2021
380
0.120
Why?
Delivery of Health Care
1
2023
948
0.120
Why?
Phenotype
1
2024
3205
0.120
Why?
Tandem Mass Spectrometry
2
2024
533
0.120
Why?
Cost-Benefit Analysis
1
2018
593
0.120
Why?
Research Design
2
2019
1116
0.120
Why?
Treatment Outcome
6
2021
10821
0.120
Why?
Kidney Diseases
1
2019
407
0.120
Why?
Exercise Therapy
2
2017
435
0.120
Why?
Costs and Cost Analysis
1
2015
207
0.110
Why?
Patient Compliance
1
2019
586
0.110
Why?
Sleep Apnea Syndromes
1
2015
89
0.110
Why?
Indoles
1
1997
415
0.110
Why?
Hypoglycemia
1
2019
443
0.110
Why?
Income
1
2015
201
0.110
Why?
Somatostatin
1
2014
62
0.110
Why?
Logistic Models
1
2019
2064
0.110
Why?
Pneumonia
1
2019
638
0.110
Why?
Fructose
1
2014
109
0.110
Why?
Employment
1
2015
177
0.110
Why?
Recovery of Function
2
2015
662
0.100
Why?
Health Personnel
1
2019
699
0.100
Why?
Metabolic Diseases
1
2014
108
0.100
Why?
Smoking
2
2012
1639
0.100
Why?
Multicenter Studies as Topic
1
2014
308
0.100
Why?
Cost of Illness
1
2015
304
0.100
Why?
C-Reactive Protein
1
2015
411
0.100
Why?
Oxygen Consumption
4
2016
684
0.100
Why?
Fatty Acids, Monounsaturated
1
2012
54
0.100
Why?
Qualitative Research
1
2019
1361
0.100
Why?
Models, Theoretical
1
2016
576
0.090
Why?
Homeostasis
1
2016
622
0.090
Why?
Aged, 80 and over
3
2019
7593
0.090
Why?
Adult Children
1
2011
23
0.090
Why?
Prospective Studies
3
2019
7598
0.090
Why?
Depressive Disorder, Major
1
2015
366
0.090
Why?
Mitochondria
1
2018
947
0.090
Why?
Placebos
2
2009
207
0.090
Why?
Practice Guidelines as Topic
1
2019
1580
0.090
Why?
Adipocytes
1
2012
215
0.090
Why?
Diabetes, Gestational
1
2015
316
0.090
Why?
Health Behavior
2
2023
764
0.090
Why?
Age Factors
1
2018
3301
0.090
Why?
Sitagliptin Phosphate
1
2010
33
0.090
Why?
Family Health
1
2011
200
0.080
Why?
Comorbidity
1
2015
1618
0.080
Why?
Health Knowledge, Attitudes, Practice
1
2019
1332
0.080
Why?
Metabolomics
1
2015
679
0.080
Why?
Longevity
1
2011
165
0.080
Why?
C-Peptide
1
2010
163
0.080
Why?
Quality of Life
3
2019
2870
0.080
Why?
Mitochondria, Muscle
2
2021
116
0.080
Why?
Disease Progression
3
2024
2755
0.080
Why?
Menopause
1
2011
316
0.070
Why?
Leisure Activities
1
2008
32
0.070
Why?
Delphi Technique
2
2019
273
0.070
Why?
Blood Pressure
1
2014
1776
0.070
Why?
Body Composition
1
2011
668
0.070
Why?
Risk Assessment
3
2015
3439
0.060
Why?
Predictive Value of Tests
1
2012
2039
0.060
Why?
Fibrinogen
2
2018
170
0.060
Why?
Cohort Studies
4
2021
5730
0.060
Why?
Postoperative Complications
1
1997
2641
0.060
Why?
Multivariate Analysis
1
2009
1524
0.060
Why?
Diabetes Mellitus, Type 1
2
2012
3708
0.060
Why?
Mass Screening
1
2013
1264
0.060
Why?
Regression Analysis
2
2019
1029
0.060
Why?
Aging
1
2015
1866
0.060
Why?
Metabolic Clearance Rate
1
2004
117
0.050
Why?
Health Expenditures
1
1986
185
0.050
Why?
Incidence
3
2019
2792
0.050
Why?
Gene Expression Profiling
2
2023
1770
0.050
Why?
Prognosis
2
2023
4031
0.050
Why?
Hormones
1
2004
143
0.050
Why?
Retrospective Studies
2
2019
15628
0.050
Why?
Depression
1
2012
1408
0.050
Why?
Menstrual Cycle
1
2003
131
0.050
Why?
Parents
1
2011
1363
0.050
Why?
Eligibility Determination
1
2023
66
0.050
Why?
Alcohol Drinking
1
2009
824
0.050
Why?
Gastrointestinal Diseases
1
2024
210
0.050
Why?
Mice, Inbred C57BL
1
2013
5792
0.050
Why?
Wakefulness
2
2015
130
0.050
Why?
Lactic Acid
1
2003
306
0.050
Why?
Animals
3
2024
37011
0.050
Why?
Proportional Hazards Models
2
2017
1263
0.050
Why?
Acute Disease
1
2024
1008
0.040
Why?
Subcellular Fractions
1
2021
82
0.040
Why?
Citric Acid Cycle
1
2021
59
0.040
Why?
Injections, Subcutaneous
1
2021
154
0.040
Why?
Sex Hormone-Binding Globulin
1
2020
59
0.040
Why?
Kinetics
1
2004
1679
0.040
Why?
Protective Agents
1
2020
40
0.040
Why?
Motor Activity
2
2015
723
0.040
Why?
Education
1
2020
108
0.040
Why?
Proprotein Convertase 9
1
2020
73
0.040
Why?
Stearoyl-CoA Desaturase
2
2010
65
0.040
Why?
Poisson Distribution
1
2019
75
0.040
Why?
Analysis of Variance
2
2013
1324
0.040
Why?
Stakeholder Participation
1
2019
77
0.040
Why?
Time Factors
3
2019
6817
0.040
Why?
E-Selectin
1
2018
58
0.040
Why?
Consensus Development Conferences as Topic
1
2018
28
0.040
Why?
Pregnancy
2
2015
6745
0.040
Why?
Subcutaneous Fat
1
2019
80
0.040
Why?
Probability
1
2019
311
0.040
Why?
Chemokine CCL2
1
2018
117
0.040
Why?
Primary Cell Culture
1
2019
172
0.040
Why?
Intercellular Adhesion Molecule-1
1
2018
139
0.040
Why?
Intra-Abdominal Fat
1
2019
91
0.040
Why?
Cell Nucleus
1
2020
615
0.030
Why?
Research
1
2020
446
0.030
Why?
Leptin
1
2018
233
0.030
Why?
Diet
3
2012
1273
0.030
Why?
Case-Control Studies
2
2017
3546
0.030
Why?
Biological Transport
1
2017
416
0.030
Why?
Adaptation, Physiological
2
2010
546
0.030
Why?
Metabolome
1
2019
350
0.030
Why?
Sequence Analysis, RNA
1
2019
451
0.030
Why?
Rats
1
2024
5676
0.030
Why?
Fatty Acids, Unsaturated
1
2016
98
0.030
Why?
Diet, Fat-Restricted
1
2015
79
0.030
Why?
Longitudinal Studies
2
2013
2857
0.030
Why?
Melatonin
1
2015
152
0.030
Why?
Interleukin-6
1
2018
778
0.030
Why?
Blood Glucose Self-Monitoring
1
2020
640
0.030
Why?
Kidney
1
2022
1472
0.030
Why?
Calorimetry
1
2013
69
0.030
Why?
Fatty Acids
1
2016
445
0.020
Why?
Insulin Receptor Substrate Proteins
1
2012
59
0.020
Why?
Risk
1
2015
905
0.020
Why?
Glycerol
1
2012
94
0.020
Why?
Sleep Wake Disorders
1
2015
283
0.020
Why?
Algorithms
1
2020
1702
0.020
Why?
RNA, Messenger
2
2010
2838
0.020
Why?
Calorimetry, Indirect
1
2010
82
0.020
Why?
Antidepressive Agents
1
2012
239
0.020
Why?
Genetic Variation
1
2015
986
0.020
Why?
Palmitic Acid
1
2010
41
0.020
Why?
Surveys and Questionnaires
1
2022
5772
0.020
Why?
Nicotine
1
2012
338
0.020
Why?
Retinoid X Receptor gamma
1
2009
4
0.020
Why?
Polysomnography
1
2010
185
0.020
Why?
PPAR alpha
1
2009
59
0.020
Why?
Gene Expression Regulation
1
2019
2615
0.020
Why?
TOR Serine-Threonine Kinases
1
2012
414
0.020
Why?
Bicycling
1
2010
116
0.020
Why?
Coronary Disease
1
2011
385
0.020
Why?
Women's Health
1
2011
371
0.020
Why?
Phospholipids
1
2010
223
0.020
Why?
Phosphorylation
1
2012
1762
0.020
Why?
Reference Values
1
2009
821
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
974
0.020
Why?
Adiposity
1
2012
517
0.020
Why?
Mice
1
2024
17843
0.020
Why?
Genetic Predisposition to Disease
1
2015
2420
0.020
Why?
Patient Education as Topic
1
2011
766
0.020
Why?
Infant Care
1
1986
45
0.020
Why?
Genotype
1
2011
1920
0.020
Why?
Infertility
1
1986
55
0.010
Why?
Health Promotion
1
2011
744
0.010
Why?
Delivery, Obstetric
1
1986
147
0.010
Why?
Maternal Health Services
1
1986
97
0.010
Why?
Follicular Phase
1
2003
39
0.010
Why?
Anaerobic Threshold
1
2003
28
0.010
Why?
Contraception
1
1986
162
0.010
Why?
Spectrophotometry, Ultraviolet
1
2003
86
0.010
Why?
Abortion, Induced
1
1986
104
0.010
Why?
Luteal Phase
1
2003
45
0.010
Why?
Catecholamines
1
2003
98
0.010
Why?
Polymorphism, Single Nucleotide
1
2011
2193
0.010
Why?
Heart Rate
1
2003
831
0.010
Why?
Infant, Newborn
1
1986
6059
0.010
Why?
Perreault's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)